|
|
(122 intermediate revisions by the same user not shown) |
Line 1: |
Line 1: |
| ==Thrombocytopenia Differential Diagnosis==
| | __NOTOC__ |
| '''Differentiating the diseases that can cause thrombocytopenia:'''
| | |
| {| | | [[Sandbox: wdx]] |
| |- style="background: #4479BA; color: #FFFFFF; text-align: center;" | | |
| ! rowspan="5" |Category
| | [[Xyz]] |
| ! colspan="2" rowspan="5" |Condition
| | |
| ! rowspan="5" |Mechanism
| | [[Abc]] |
| ! colspan="3" rowspan="4" |Mechanism
| | # [[Sandbox:Preeti]] |
| ! rowspan="5" |Inherited
| | # [[Lymphoma]] |
| ! rowspan="5" |Acquried
| | # [[Breast lumps differential diagnosis]] |
| ! colspan="10" |Clinical manifestations
| | # [[Neck masses differential diagnosis]] |
| ! colspan="10" rowspan="2" |Para−clinical findings
| | # [[Leukemia]] |
| ! colspan="1" rowspan="5" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Gold standard
| | {| class="wikitable" |
| ! rowspan="5" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Associated findings
| | |+ |
| | |- |
| | | colspan="2" |[[:Category:Risk calculator]] |
| | [[Category:Risk calculator]] |
| | |- |
| | | colspan="2" |[[Deep vein thrombosis assessment of clinical probability and risk scores]] |
| | |- |
| | | colspan="2" |[[Pulmonary embolism assessment of clinical probability and risk scores]] |
| | |- |
| | |[[Padua prediction score]] |
| | |[[widget:PaduaVTEscore]] |
| | |- |
| | |[[IMPROVE risk score calculator]] |
| | |[[Widget:IMPROVEScore]] |
| | |- |
| | |[[IMPROVEDD risk score calculator]] |
| | |[[Widget:IMPROVEDDScore]] |
| | |- |
| | |[[Caprini score calculator]] |
| | |[[Widget:CapCal]] |
| | |- |
| | |[[Wells score calculator for DVT]] |
| | |[[Widget:DVT Wells score calculator]] |
| | |- |
| | |[[Modified Wells score calculator for DVT]] |
| | |[[Widget:DVT Modified Wells score calculator]] |
| | |- |
| | |[[Pulmonary embolism Wells score calculator]] |
| | |[[widget:PE_calculator]] |
| | |- |
| | |[[Pulmonary embolism modified Wells score calculator]] |
| | |[[Widget:PE Modified Wells score calculator]] |
| | |- |
| | |[[AMUSE score calculator]] |
| | |[[Widget:AMUSE_score_calculator]] |
| | |- |
| | |[[HAMILTON score calculator]] |
| | |[[Widget:HAMILTON_score_calculator]] |
| | |- |
| | |[[Geneva score calculator]] |
| | |[[Widget:Geneva_score_calculator]] |
| | |- |
| | |[[Revised Geneva score calculator]] |
| | |[[Widget:Revised_Geneva_score_calculator]] |
| | |- |
| | |[[Simplified Geneva Score calculator]] |
| | |[[Widget:Simplified_Geneva_score_calculator]] |
| | |- |
| | |[[TIMI Risk Score for Unstable Angina or NSTEMI]] |
| | |[[Widget:TIMI_UA_NSTEMI]] |
| | |- |
| | |[[TIMI Risk Score for STEMI]] |
| | |[[Widget:TIMI_STEMI]] |
| |- | | |- |
| |- style="background: #4479BA; color: #FFFFFF; text-align: center;" | | |[[Tygerberg score]] |
| ! rowspan="4" |Age range
| | |[[widget:Tygerberg_score]] |
| ! rowspan="4" |History
| |
| ! colspan="4" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Symptoms
| |
| | colspan="4" rowspan="2" |Signs
| |
| |- | | |- |
| |- style="background: #4479BA; color: #FFFFFF; text-align: center;" | | |[[CHA2DS2-VASc Score]] |
| ! colspan="9" |Lab Findings
| | |[[Widget:CHA2DS2VASc]] |
| ! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Imaging
| |
| |- | | |- |
| |- style="background: #4479BA; color: #FFFFFF; text-align: center;" | | |[[CHADS2 score]] |
| ! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Severity
| | |[[Widget:CHADS2score]] |
| ! colspan="1" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Fever
| |
| ! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Rash
| |
| ! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Bleeding
| |
| ! rowspan="2" |BP
| |
| ! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Splenomegaly
| |
| ! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Jaundice
| |
| ! rowspan="2" |Other
| |
| ! colspan="3" |CBC
| |
| ! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |PBS
| |
| ! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Bone marrow exam
| |
| ! rowspan="2" |PT
| |
| ! rowspan="2" |PTT
| |
| ! rowspan="2" |BT
| |
| ! rowspan="2" |UA
| |
| |- | | |- |
| |- style="background: #4479BA; color: #FFFFFF; text-align: center;" | | |[[HAS-BLED score]] |
| !Decreased platelet production
| | |[[Widget:HASBLEDscore]] |
| !Platelet destruction in bloodstream
| |
| !Platelet destruction in spleen/liver
| |
| !Plt
| |
| !HB
| |
| !WBC
| |
| |- | | |- |
| ! rowspan="15" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Hematology
| | |[[The GRACE risk score]] |
| ! rowspan="4" align="center" style="background:#DCDCDC;" + |Bone marrow disorders
| | |[[Widget:GRACEscore]] |
| ! align="center" style="background:#DCDCDC;" + |Myelodysplastic syndromes
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + | +
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + | | |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| |- | | |- |
| ! align="center" style="background:#DCDCDC;" + |Aplastic anemia
| |
| !
| |
| | +
| |
| | | | | |
| | | | | |
| |
| |
| |
| |
| |
| |
| |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| |
| |
| |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="left" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| |- | | |- |
| ! align="center" style="background:#DCDCDC;" + |Acute leukemia
| | |[[Ranson criteria]] |
| !
| | [[Acute pancreatitis diagnostic criteria]] |
| | + | | |[[Widget:RansonScore]] |
| | |- |
| | |[[Apgar score]] |
| | |[[Widget:Apgarscore]] |
| | |- |
| | |[[Glasgow coma scale]] |
| | |[[Widget:Adult_GCS]] |
| | |- |
| | |[[Pediatric Glasgow Coma Scale]] |
| | |[[Widget:PGCS]] |
| | |- |
| | |[[Cincinnati stroke scale]] |
| | |[[Widget:Cincinnati_Stroke_Scale]] |
| | |- |
| | |[[DIPSS Plus Score]] |
| | |[[Widget:DIPSS_Plus_Score]] |
| | |- |
| | | colspan="2" |[[ICU scoring systems]] |
| | |- |
| | |[[APACHE II]] |
| | |[[Widget:APACHEII]] |
| | |- |
| | |[[SAPS II]] |
| | |[[Widget:SAPSII]] |
| | |- |
| | |[[SAPS III]] |
| | |[[Widget:SAPSIII]] |
| | |- |
| | |[[PIM2]] |
| | | | | |
| | | | |} |
| |
| | ==Table== |
| |
| | {| |
| |
| | ! align="center" style="background:#4479BA; color: #FFFFFF;" + |Complications |
| |
| | ! align="center" style="background:#4479BA; color: #FFFFFF;" + |Polymyositis |
| | align="center" style="background:#F5F5F5;" + |
| | ! align="center" style="background:#4479BA; color: #FFFFFF;" + |Dermatomyositis |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | | |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| |
| |
| |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="left" style="background:#F5F5F5;" + |
| |
| |- | | |- |
| ! align="center" style="background:#DCDCDC;" + |Paroxysmal nocturnal hemoglobinuria (PNH) | | ! align="center" style="background:#DCDCDC;" + |[[Cancer|Malignancy]] |
| !
| |
| | +
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| |
| |
| |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="left" style="background:#F5F5F5;" + | | | | align="left" style="background:#F5F5F5;" + | |
| | align="center" style="background:#F5F5F5;" + |
| | *[[Lung]] |
| | align="center" style="background:#F5F5F5;" + |Diagnosis of exclusion
| |
| | align="left" style="background:#F5F5F5;" + | | | | align="left" style="background:#F5F5F5;" + | |
| | *[[Lung]] |
| | |} |
| | <br> |
| | ===Calculation of the Padua Prediction Score=== |
| | Shown below is a calculator using the predictive score for VTE among hospitalized medical patients. Check all boxes that apply to your patient: |
| | |
| | {| style="border: 0; float: left; width: 45%; position: float; background: #104E8B; border-radius: 10px 10px 10px 10px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5); margin: 0 0 0 0; padding: 5px 5px; font-weight: bold;" |
| | | colspan="2" style="text-align: center; color: #FFFFFF; font-size: 120%;" | IMPROVE Bleeding Risk Score |
| |- | | |- |
| ! rowspan="3" align="center" style="background:#DCDCDC;" + |Thrombotic microangiopathy (TMA) | | ! style=" text-align: left; color: #4479BA; background: #FFFFFF; padding: 2px 10px; border-radius: 5px 5px 5px 5px; text-shadow: 0 0 0 rgba(0, 0, 0, 0.2); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" |Variable |
| ! align="center" style="background:#DCDCDC;" + |Thrombotic thrombocytopenic purpura (TTP) | | ! style=" text-align: center; color: #4479BA; background: #FFFFFF; border-radius: 5px 5px 5px 5px; text-shadow: 0 0 0 rgba(0, 0, 0, 0.2); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" |Score |
| !
| |
| !
| |
| !+
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| |- | | |- |
| ! align="center" style="background:#DCDCDC;" + |Hemolytic uremic syndrome (HUS) | | ! style=" text-align: left; color: #FFFFFF; background: #4479BA; padding: 2px 10px; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" |Active gastric or duodenal ulcer |
| !
| | | style=" text-align: center; color: #FFFFFF; background: #4479BA; padding: 2px 10px; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" |4.5 |
| !
| |
| !+
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| |- | | |- |
| ! align="center" style="background:#DCDCDC;" + |DIC | | ! style=" text-align: left; color: #FFFFFF; background: #4479BA; padding: 2px 10px; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" |Prior bleeding within the last 3 months |
| !
| | | style=" text-align: center; color: #FFFFFF; background: #4479BA; padding: 2px 10px; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" |4 |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| |- | | |- |
| ! rowspan="7" align="center" style="background:#DCDCDC;" + |Congenital platelet disorders | | ! style=" text-align: left; color: #FFFFFF; background: #4479BA; padding: 2px 10px; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" |Thrombocytopenia (<50x10<sup>9</sup>/L) |
| ! align="center" style="background:#DCDCDC;" + |MYH-9 related disorders
| | | style=" text-align: center; color: #FFFFFF; background: #4479BA; padding: 2px 10px; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" |4 |
| | | | |- |
| |
| | ! style=" text-align: left; color: #FFFFFF; background: #4479BA; padding: 2px 10px; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" |Age ≥ 85 years |
| |
| | | style=" text-align: center; color: #FFFFFF; background: #4479BA; padding: 2px 10px; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" |3.5 |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | | |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| |
| |
| |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + | | |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="left" style="background:#F5F5F5;" + |
| |
| |- | | |- |
| ! align="center" style="background:#DCDCDC;" + |Bernard-Soulier syndrome | | ! style=" text-align: left; color: #FFFFFF; background: #4479BA; padding: 2px 10px; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" |Liver failure (INR>1.5) |
| |
| | | style=" text-align: center; color: #FFFFFF; background: #4479BA; padding: 2px 10px; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" |2.5 |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| |
| |
| | align="left" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| |
| |
| |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | | |
| | align="center" style="background:#F5F5F5;" + | | |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="left" style="background:#F5F5F5;" + |
| |
| |- | | |- |
| ! align="center" style="background:#DCDCDC;" + |Gray platelet syndrome | | ! style=" text-align: left; color: #FFFFFF; background: #4479BA; padding: 2px 10px; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" |Severe kidney failure (GFR< 30 mL/min/m<sup>2</sup>) |
| |
| | | style=" text-align: center; color: #FFFFFF; background: #4479BA; padding: 2px 10px; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" |2.5 |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| |
| |
| | align="left" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| |
| |
| |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | | |
| | align="center" style="background:#F5F5F5;" + | | |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="left" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="left" style="background:#F5F5F5;" + |
| |
| |- | | |- |
| ! align="center" style="background:#DCDCDC;" + |Wiskott-Aldrich syndrome | | ! style=" text-align: left; color: #FFFFFF; background: #4479BA; padding: 2px 10px; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" |Admission to ICU or CCU |
| |
| | | style=" text-align: center; color: #FFFFFF; background: #4479BA; padding: 2px 10px; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" |2.5 |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| |
| |
| |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | | |
| | align="center" style="background:#F5F5F5;" + | | |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="left" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="left" style="background:#F5F5F5;" + |
| |
| |- | | |- |
| ! align="center" style="background:#DCDCDC;" + |Thrombocytopenia with absent radius (TAR) syndrome | | ! style=" text-align: left; color: #FFFFFF; background: #4479BA; padding: 2px 10px; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" |Central venous catheter |
| |
| | | style=" text-align: center; color: #FFFFFF; background: #4479BA; padding: 2px 10px; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" |2 |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| |
| |
| | align="left" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| |
| |
| |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | | |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="left" style="background:#F5F5F5;" + |
| |
| |- | | |- |
| ! align="center" style="background:#DCDCDC;" + |Alport syndrome | | ! style=" text-align: left; color: #FFFFFF; background: #4479BA; padding: 2px 10px; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" |Rheumatic disease |
| |
| | | style=" text-align: center; color: #FFFFFF; background: #4479BA; padding: 2px 10px; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" |2 |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| |
| |
| | align="left" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| |
| |
| |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | | |
| | align="center" style="background:#F5F5F5;" + | | |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="left" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="left" style="background:#F5F5F5;" + |
| |
| |- | | |- |
| ! align="center" style="background:#DCDCDC;" + |Von Willebrand disease | | ! style=" text-align: left; color: #FFFFFF; background: #4479BA; padding: 2px 10px; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" |Active malignancy |
| |
| | | style=" text-align: center; color: #FFFFFF; background: #4479BA; padding: 2px 10px; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" |2 |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| |
| |
| |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | | |
| | align="center" style="background:#F5F5F5;" + | | |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| |- | | |- |
| ! align="center" style="background:#DCDCDC;" + |Nutrient deficiencies | | ! style=" text-align: left; color: #FFFFFF; background: #4479BA; padding: 2px 10px; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" |Age: 40-84 years |
| ! align="center" style="background:#DCDCDC;" + |Folate, vitamin B12, copper
| | | style=" text-align: center; color: #FFFFFF; background: #4479BA; padding: 2px 10px; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" |1.5 |
| |an autoimmune mechanism | |
| !+
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| |- | | |- |
| |- style="background: #4479BA; color: #FFFFFF; text-align: center;"
| | ! style=" text-align: left; color: #FFFFFF; background: #4479BA; padding: 2px 10px; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" |Male |
| !Category
| | | style=" text-align: center; color: #FFFFFF; background: #4479BA; padding: 2px 10px; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" |1 |
| ! colspan="2" |Condition
| |
| !Mechanism
| |
| !Decreased platelet production
| |
| !Platelet destruction in bloodstream
| |
| !Platelet destruction in spleen/liver
| |
| !Inherited
| |
| !Acquried
| |
| !Age range
| |
| !History
| |
| !Severity
| |
| !Fever
| |
| !Rash
| |
| !Bleeding
| |
| !BP
| |
| !Splenomegaly
| |
| !Jaundice
| |
| !Other signs
| |
| !Plt
| |
| !HB
| |
| !WBC
| |
| !PBS
| |
| !Bone marrow exam
| |
| !PT
| |
| !PTT
| |
| !BT
| |
| !UA
| |
| !Imaging
| |
| !Gold standard
| |
| !Associated findings
| |
| |- | | |- |
| ! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Rheumatologic/autoimmune disorders | | ! style=" text-align: left; color: #FFFFFF; background: #4479BA; padding: 2px 10px; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" |Moderate kidney failure (GFR: 30-59 mL/min/m<sup>2</sup>) |
| ! align="center" style="background:#DCDCDC;" + |Immune thrombocytopenia
| | | style=" text-align: center; color: #FFFFFF; background: #4479BA; padding: 2px 10px; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" |1 |
| !
| |
| |Antibody-mediated platelet destruction
| |
| |
| |
| | +
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| | align="center" style="background:#F5F5F5;" + |Moderate to severe
| |
| | align="center" style="background:#F5F5F5;" + | -
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | | |
| |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| |- | | |- |
| ! align="center" style="background:#DCDCDC;" + |Systemic lupus erythematosus (SLE) | | ! colspan="2" style=" text-align: left; color: #4479BA; background: #FFFFFF; padding: 2px 10px; border-radius: 5px 5px 5px 5px; text-shadow: 0 0 0 rgba(0, 0, 0, 0.2); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" |Result: |
| !
| |
| !
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| |
| |
| |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| |
| |
| | align="center" style="background:#F5F5F5;" + | | |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| |- | | |- |
| ! align="center" style="background:#DCDCDC;" + |Antiphospholipid syndrome (APS) | | ! colspan="2" style=" text-align: left; color: #4479BA; background: #FFFFFF; padding: 2px 10px; border-radius: 5px 5px 5px 5px; text-shadow: 0 0 0 rgba(0, 0, 0, 0.2); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" |Interpretation: |
| !
| | |} |
| !autoantibody-mediated syndrome
| | <br style="clear:left" /> |
| !
| | |
| !
| | ===Calculation of the test Prediction Score=== |
| !
| | Shown below is a calculator using the predictive score for VTE among hospitalized medical patients. Check all boxes that apply to your patient: |
| !
| | |
| !
| | {| style="border: 0; float: left; width: 45%; position: float; background: #104E8B; border-radius: 10px 10px 10px 10px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5); margin: 0 0 0 0; padding: 5px 5px; font-weight: bold;" |
| !
| | | colspan="2" style="text-align: center; color: #FFFFFF; font-size: 120%;" | IMPROVE Bleeding Risk Score |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| |- | | |- |
| ! align="center" style="background:#DCDCDC;" + |Felty's syndrome | | ! style=" text-align: left; color: #4479BA; background: #FFFFFF; padding: 2px 10px; border-radius: 5px 5px 5px 5px; text-shadow: 0 0 0 rgba(0, 0, 0, 0.2); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" |Variable |
| !
| | ! style=" text-align: center; color: #4479BA; background: #FFFFFF; border-radius: 5px 5px 5px 5px; text-shadow: 0 0 0 rgba(0, 0, 0, 0.2); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" |Score |
| !splenomegaly
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| |- | | |- |
| ! rowspan="7" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Infection-induced | | ! rowspan="2" style=" text-align: left; color: #FFFFFF; background: #4479BA; padding: 2px 10px; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" |Gender |
| ! rowspan="3" align="center" style="background:#DCDCDC;" + |Bacterial infections
| | | style=" text-align: center; color: #FFFFFF; background: #4479BA; padding: 2px 10px; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" |Female |
| ! align="center" style="background:#DCDCDC;" + |Sepsis
| |
| !Direct bone marrow suppression
| |
| !+
| |
| !+
| |
| !
| |
| !
| |
| !
| |
| |
| |
| |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | | |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| |
| |
| |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| |- | | |- |
| ! align="center" style="background:#DCDCDC;" + |Helicobacter pylori
| | | style=" text-align: center; color: #FFFFFF; background: #4479BA; padding: 2px 10px; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" |Male |
| !Immune thrombocytopenia
| |
| !
| |
| !+
| |
| !
| |
| !
| |
| !
| |
| |
| |
| |
| |
| | align="center" style="background:#F5F5F5;" + | | |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| |
| |
| |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| |- | | |- |
| ! align="center" style="background:#DCDCDC;" + |Tick-borne infection | | ! rowspan="4" style=" text-align: left; color: #FFFFFF; background: #4479BA; padding: 2px 10px; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" |Age |
| |
| | | style=" text-align: center; color: #FFFFFF; background: #4479BA; padding: 2px 10px; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" |0-70 |
| |
| |
| | +
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| |
| |
| |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | | |
| | align="center" style="background:#F5F5F5;" + | | |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| |- | | |- |
| ! rowspan="2" align="center" style="background:#DCDCDC;" + |Viral infections
| | | style=" text-align: center; color: #FFFFFF; background: #4479BA; padding: 2px 10px; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" |71-80 |
| ! align="center" style="background:#DCDCDC;" + |HIV
| |
| !
| |
| * Direct toxicity to megakaryocytes
| |
| * An ITP-like condition called primary HIV-associated thrombocytopenia (PHAT)
| |
| * Secondary opportunistic infections
| |
| !+
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| |- | | |- |
| ! align="center" style="background:#DCDCDC;" + |Other viruses such as rubella, mumps, varicella, parvovirus, hepatitis C, & Epstein-Barr virus
| | | style=" text-align: center; color: #FFFFFF; background: #4479BA; padding: 2px 10px; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" |81-90 |
| !
| |
| !+
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| |- | | |- |
| ! rowspan="2" align="center" style="background:#DCDCDC;" + |Intracellular parasites
| | | style=" text-align: center; color: #FFFFFF; background: #4479BA; padding: 2px 10px; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" |>90 |
| ! align="center" style="background:#DCDCDC;" + |Malaria
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | | |
| |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| |- | | |- |
| ! align="center" style="background:#DCDCDC;" + |Babesiosis | | ! rowspan="5" style=" text-align: left; color: #FFFFFF; background: #4479BA; padding: 2px 10px; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" |Hgb ('''g/dL)''' |
| |
| | | style=" text-align: center; color: #FFFFFF; background: #4479BA; padding: 2px 10px; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" |>17 '''g/dL''' |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| |
| |
| |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | | |
| | align="center" style="background:#F5F5F5;" + | | |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| |- | | |- |
| |- style="background: #4479BA; color: #FFFFFF; text-align: center;" | | | style=" text-align: center; color: #FFFFFF; background: #4479BA; padding: 2px 10px; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" |15.5-17 '''g/dL''' |
| !Category
| |
| ! colspan="2" |Condition
| |
| !Mechanism
| |
| !Decreased platelet production
| |
| !Platelet destruction in bloodstream
| |
| !Platelet destruction in spleen/liver
| |
| !Inherited
| |
| !Acquried
| |
| !Age range
| |
| !History
| |
| !Severity
| |
| !Fever
| |
| !Rash
| |
| !Bleeding
| |
| !BP
| |
| !Splenomegaly
| |
| !Jaundice
| |
| !Other signs
| |
| !Plt
| |
| !HB
| |
| !WBC
| |
| !PBS
| |
| !Bone marrow exam
| |
| !PT
| |
| !PTT
| |
| !BT
| |
| !UA
| |
| !Imaging
| |
| !Gold standard
| |
| !Associated findings
| |
| |- | | |- |
| ! rowspan="5" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Medication/toxicity
| | | style=" text-align: center; color: #FFFFFF; background: #4479BA; padding: 2px 10px; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" |12.5-15.5 '''g/dL''' |
| ! align="center" style="background:#DCDCDC;" + |Drug-induced immune thrombocytopenia
| |
| ! align="left" style="background:#DCDCDC;" + |
| |
| * Antibiotics
| |
| ** Sulfonamides
| |
| ** Ampicillin
| |
| ** Piperacillin
| |
| ** Vancomycin
| |
| ** Rifampin
| |
| * Older antiepileptic agents
| |
| ** carbamazepine
| |
| ** Phenytoin
| |
| * Quinine
| |
| |Occurrence of drug-dependent, platelet-reactive antibodies
| |
| |
| |
| | +
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| |
| |
| |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| |- | | |- |
| ! align="center" style="background:#DCDCDC;" + |Heparin-induced thrombocytopenia
| | | style=" text-align: center; color: #FFFFFF; background: #4479BA; padding: 2px 10px; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" |12.5-11 '''g/dL''' |
| !
| |
| |
| |
| |
| |
| | +
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| |
| |
| |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| |- | | |- |
| ! align="center" style="background:#DCDCDC;" + |Cytotoxic chemotherapy
| | | style=" text-align: center; color: #FFFFFF; background: #4479BA; padding: 2px 10px; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" |<11 '''g/dL''' |
| !
| |
| |
| |
| | + | |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| |
| |
| |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| |- | | |- |
| ! align="center" style="background:#DCDCDC;" + |Radiation therapy | | ! rowspan="2" style=" text-align: left; color: #FFFFFF; background: #4479BA; padding: 2px 10px; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" |CrCl (mL/min) |
| !
| | | style=" text-align: center; color: #FFFFFF; background: #4479BA; padding: 2px 10px; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" |30-60 mL/min |
| |Predictable, dose-dependent myelosuppression
| |
| | +
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| |
| |
| |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | | |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| |- | | |- |
| ! align="center" style="background:#DCDCDC;" + |OTC agents
| | | style=" text-align: center; color: #FFFFFF; background: #4479BA; padding: 2px 10px; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" |15-30 mL/min |
| ! align="center" style="background:#DCDCDC;" + |Quinine-containing beverages
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| |
| |
| |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| |- | | |- |
| ! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |GI | | ! rowspan="2" style=" text-align: left; color: #FFFFFF; background: #4479BA; padding: 2px 10px; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" |Albumin |
| ! align="center" style="background:#DCDCDC;" + |Chronic liver disease
| | | style=" text-align: center; color: #FFFFFF; background: #4479BA; padding: 2px 10px; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" |>3.5 g/dL |
| !
| |
| |
| |
| | +
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| | align="center" style="background:#F5F5F5;" + |Mild
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + | | |
| |
| |
| |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| |- | | |- |
| ! align="center" style="background:#DCDCDC;" + |Portal hypertension
| | | style=" text-align: center; color: #FFFFFF; background: #4479BA; padding: 2px 10px; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" |≤3.5 g/dL |
| !
| |
| |
| |
| | | |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| |
| |
| |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| | align="center" style="background:#F5F5F5;" + |
| |
| |- | | |- |
| |- style="background: #4479BA; color: #FFFFFF; text-align: center;"
| | ! rowspan="2" style=" text-align: left; color: #FFFFFF; background: #4479BA; padding: 2px 10px; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" |D-dimer |
| !Category
| | | style=" text-align: center; color: #FFFFFF; background: #4479BA; padding: 2px 10px; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" |≥1 µg/mL |
| ! colspan="2" |Condition
| |
| !Mechanism
| |
| !Decreased platelet production
| |
| !Platelet destruction in bloodstream
| |
| !Platelet destruction in spleen/liver
| |
| !Inherited
| |
| !Acquried
| |
| !Age range
| |
| !History
| |
| !Severity
| |
| !Fever
| |
| !Rash
| |
| !Bleeding
| |
| !BP
| |
| !Splenomegaly
| |
| !Jaundice
| |
| !Other signs
| |
| !Plt
| |
| !HB
| |
| !WBC
| |
| !PBS
| |
| !Bone marrow exam
| |
| !PT
| |
| !PTT
| |
| !BT
| |
| !UA
| |
| !Imaging
| |
| !Gold standard
| |
| !Associated findings
| |
| |- | | |- |
| ! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Vascular
| | | style=" text-align: center; color: #FFFFFF; background: #4479BA; padding: 2px 10px; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" |<1 µg/mL |
| ! align="center" style="background:#DCDCDC;" + |Giant capillary hemangioma
| |
| !
| |
| !platelet destruction
| |
| !
| |
| !+
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| |- | | |- |
| ! align="center" style="background:#DCDCDC;" + |Aortic aneurysm | | ! style=" text-align: left; color: #FFFFFF; background: #4479BA; padding: 2px 10px; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" |ICU admission |
| !
| | | style=" text-align: center; color: #FFFFFF; background: #4479BA; padding: 2px 10px; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" | |
| !platelet destruction
| |
| !
| |
| !+
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| |- | | |- |
| ! align="center" style="background:#DCDCDC;" + |Cardiopulmonary bypass | | ! style=" text-align: left; color: #FFFFFF; background: #4479BA; padding: 2px 10px; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" |Acute stroke on hospitalization |
| !
| | | style=" text-align: center; color: #FFFFFF; background: #4479BA; padding: 2px 10px; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" | |
| !platelet destruction
| |
| !
| |
| !+
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| |- | | |- |
| ! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other | | ! style=" text-align: left; color: #FFFFFF; background: #4479BA; padding: 2px 10px; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" |History of VTE |
| ! align="center" style="background:#DCDCDC;" + |Alcohol
| | | style=" text-align: center; color: #FFFFFF; background: #4479BA; padding: 2px 10px; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" | |
| !
| |
| !
| |
| !+
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| |- | | |- |
| ! align="center" style="background:#DCDCDC;" + |Post-transfusion purpura | | ! colspan="2" style=" text-align: left; color: #4479BA; background: #FFFFFF; padding: 2px 10px; border-radius: 5px 5px 5px 5px; text-shadow: 0 0 0 rgba(0, 0, 0, 0.2); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" |Result: |
| !
| |
| !immune-mediated platelet destruction
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| |- | | |- |
| ! align="center" style="background:#DCDCDC;" + |Gestational thrombocytopenia | | ! colspan="2" style=" text-align: left; color: #4479BA; background: #FFFFFF; padding: 2px 10px; border-radius: 5px 5px 5px 5px; text-shadow: 0 0 0 rgba(0, 0, 0, 0.2); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" |Interpretation: |
| !
| |
| !
| |
| !
| |
| !+
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| !
| |
| |} | | |} |
| | <br style="clear:left" /> |
| | |
| | ===Interpretation of the Padua Prediction Score=== |
| | The interpretation of the score is as follows: |
| | * Score ≥ 4: High risk for VTE |
| | * Score < 4: Low risk for VTE |
| | ==References== |
| <references /> | | <references /> |